The content on this site is intended for healthcare professionals only
ASCO 2022: Panel discussion on bladder preservation
Published: 6 Jun 2022
Views: 1608
Dr Petros Grivas, Prof Rob Jones, Prof Phil Cornford and Prof Kurt Miller
Dr Petros Grivas (University of Washington, Seattle, USA), Prof Rob Jones (The university of Glasgow, Glasgow, UK), Prof Phil Cornford (Royal Liverpool University Hospital, Liverpool, UK) and Prof Kurt Miller (Charité - Universitätsmedizin Berlin, Berlin, Germany) discuss bladder preservation data from ASCO 2022.
Initially, Prof Jones and Prof Cornford discuss the current strategies in bladder preservation with Dr Grivas.
The panel then discusses the problems with current strategies and the trials currently in progress from ASCO 2022.
They conclude by talking about what the future holds for bladder cancer patients.
This programme is supported by an unrestricted educational grant from Janssen.
Related Videos
ASCO 2022: The latest in RCC
Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri
17 Jun 2022
ASCO 2022: Latest in prostate cancer, including PARP inhibitors
Dr Neal Shore, Prof Cora Sternberg, Prof Eleni Efstathiou and Prof Phil Cornford
6 Jun 2022
ASCO GU 2022: Prostate roundup
Prof Eleni Efstathiou, Prof Axel Merseburger and Dr Neal Shore
20 Apr 2022
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
8 Dec 2021
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt ...
26 Feb 2021
Clinical genomic testing in prostate cancer
Laurie M Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
PARP inhibitors for prostate cancer - Nurse's view
Laurie M. Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
4 Nov 2020